Please check the following points before proceeding.
3. Article Publication Charge (APC)
Peer review policies
Click here
to read
Publication
Once an article is accepted, it is published in
CytoJournal immediately as a provisional PDF file. The paper
will subsequently be published in both fully browseable web form
(HTML), and as a formatted PDF. Tthe HTML of the article will
then be available through CytoJournal and PubMed Central,
and will also be included in PubMed.
Article-processing charges (APC)
CytoJournal levies an article-processing charge (APC) for
every accepted article, to cover the costs incurred by open
access publication. Currently the article-processing charge is
US$1500.
APC is not applicable for the year 2008. But the generosity
of readers and authors to support this ‘open access charter’ of
CytoJournal to allow dissemination of scientific peer-reviewed
cytopathology literature around the globe would be highly
appreciated.
APC is waived for following:
- Cytopathology Foundation (CF)
members. Please click here to
become CF member (US $ 40 / year OR US $ 1000 for life)
- All members of organizations/societies/and other
entities as ‘CytoJ OA Stewards-Plus’. Please
click here to check if your
society-organization is ‘CytoJ OA Stewards-Plus’
APC is subsidized to US$ 500 for following:
All members of organizations/societies/and other entities as
‘CytoJ OA Stewards’. Please
click here to check if your society-organization has
joined as ‘CytoJ OA Stewards’ without any financial
obligation to it.
APC may also be waived or subsidized to:
Group with reasonable proof of financial hardship to
afford any of the pathways shown above.
Waivers may be granted, particularly for authors from
developing countries. For further details, see
more information about article-processing
charges
Editorial policies
Any manuscript submitted to CytoJournal must not already have
been published in another journal or be under consideration by
any other journal, although it may have been deposited on a
preprint server.
Manuscripts must not have already been published in any
journal or other citable form, with the exception that the
journal is willing to consider peer-reviewing manuscripts that
are translations of articles originally published in another
language. In this case, the consent of the journal in which the
article was originally published must be obtained and the fact
that the article has already been published must be made clear
on submission and stated in the abstract.
Manuscripts that are derived from papers presented at
conferences can be submitted unless they have been published as
part of the conference proceedings in a peer reviewed journal.
Authors are required to ensure that no material submitted as
part of a manuscript infringes existing copyrights, or the
rights of a third party. Authors who publish in CytoJournal
retain copyright to their work (more information
http://creativecommons.org/licenses/by/2.0/ ).
Correspondence concerning articles published in CytoJournal is
encouraged .
Guideline for duplicate publication as flowchart is at COPE:
http://www.publicationethics.org.uk/flow-charts/cope-flowcharts-optimal.pdf/view
Submission of a manuscript to CytoJournal implies that all
authors have read and agreed to its content, and that any
experimental research that is reported in the manuscript has
been performed with the approval of an appropriate ethics
committee and Institutional Review Board (IRB) as indicated by
local standards and laws.
Research carried out on humans must be in compliance with the
Helsinki
Declaration
http://www.wma.net/e/policy/b3.htm , and any
experimental research on animals must follow internationally
recognized guidelines. A statement to this effect must appear in
the Methods section of the manuscript, including the name of the
body which gave approval, with a reference number where
appropriate. Informed consent must also be documented.
Manuscripts may be rejected if the editorial office considers
that the research has not been carried out within an ethical
framework, e.g. if the severity of the experimental procedure is
not justified by the value of the knowledge gained.
Generic drug names should generally be used. When proprietary
brands are used in research, include the brand names in
parentheses in the Methods section.
We ask authors of CytoJournal papers to complete a
declaration of competing interests, which should be provided as
a separate section of the manuscript, to follow the
Acknowledgements.
Competing interests
A competing interest exists when your interpretation of data or
presentation of information may be influenced by your personal
or financial relationship with other people or organizations.
Authors should disclose any financial competing interests but
also any non-financial competing interests that may cause them
embarrassment were they to become public after the publication
of the manuscript.
Authors are required to complete a declaration of competing
interests. All competing interests that are declared will be
listed at the end of published articles. Where an author gives
no competing interests, the listing will read 'The author(s)
declare that they have no competing interests'.
When completing your declaration, please consider the
following questions:
Financial competing interests
- In the past five years have you received reimbursements,
fees, funding, or salary from an organization that may in
any way gain or lose financially from the publication of
this manuscript, either now or in the future? Is such an
organization financing this manuscript (including the
article-processing charge)? If so, please specify.
- Do you hold any stocks or shares in an organization that
may in any way gain or lose financially from the publication
of this manuscript, either now or in the future? If so,
please specify.
- Do you hold or are you currently applying for any
patents relating to the content of the manuscript? Have you
received reimbursements, fees, funding, or salary from an
organization that holds or has applied for patents relating
to the content of the manuscript? If so, please specify.
- Do you have any other financial competing interests? If
so, please specify.
Non-financial competing interests
Are there any non-financial competing interests (political,
personal, religious, ideological, academic, intellectual,
commercial or any other) to declare in relation to this
manuscript? If so, please specify.
If you are unsure as to whether you, or one your co-authors, has
a competing interest please discuss it with the editorial
office.
Where an author gives no competing interests, the listing
will read 'The author(s) declare that they have no competing
interests'. Much has been written about competing interests
(or conflict of interest, as other journals call it) within
scientific research, but the following articles provide some
background:
R Smith: Beyond conflict of interest. BMJ 1998, 317 :291-292
R Smith: Making progress with competing interests. BMJ 2002,
325 :1375-1376
CD DeAngelis, PB Fontanarosa, A Flanagin: Reporting
financial conflicts of interest and relationships between
investigators and research sponsors. JAMA 2001, 286 :89-9
K Morin, H Rakatansky, FA Riddick Jr, LJ Morse, JM O'Bannon
3rd, MS Goldrich, P Ray, M Weiss, RM Sade, MA Spillman:
Managing conflicts of interest in the conduct of clinical
trials. JAMA 2002, 287 :78-84
For all articles that include information or clinical
photographs relating to individual patients, written and signed
consent from each patient to publish must also be mailed or
faxed to the editorial staff. The manuscript should also include
a statement to this effect in the Acknowledgements section, as
follows: "Written consent for publication was obtained from
the patient or their relative."
CytoJournal supports initiatives to improve the performance
and reporting of clinical trials, part of which includes
prospective registering and numbering of trials. While there are
initiatives to ensure that all clinical trials are registered
(most notably the recent statement from the International
Committee of Medical Journal Editors - see
http://www.icmje.org/clin_trialup.htm ), we are focusing on
controlled trials of healthcare interventions, for now. Authors
of protocols or reports of controlled trials of health care
interventions must register their trial prior to submission in a
suitable publicly accessible registry. The trial registers that
currently meet all of the ICMJE guidelines can be found at
http://www.icmje.org/faq.pdf .
The trial registration number should be included as the last
line of the abstract of the manuscript.
CytoJournal also supports initiatives aimed at improving the
reporting of biomedical research. Checklists have been developed
for randomized controlled trials (CONSORT
http://www.consort-statement.org/index.aspx?o=1065 ),
systematic reviews (QUOROM
http://www.consort-statement.org/index.aspx?o=1065 ),
meta-analyses of observational studies (MOOSE
http://www.consort-statement.org/index.aspx?o=1065 ),
diagnostic accuracy studies (STARD
http://www.consort-statement.org/index.aspx?o=1065 )
and qualitative studies (RATS (see at end). Authors are
requested to make use of these when drafting their manuscript
and peer reviewers will also be asked to refer to these
checklists when evaluating these studies. For authors of
systematic reviews, a supplementary file, linked from the
Methods section, should reproduce all details concerning the
search strategy. For an example of how a search strategy should
be presented, see the Cochrane Reviewers' Handbook
http://www.cochrane.dk/cochrane/..../r_studies_and_organizing_search_results.htm
.
Authors from pharmaceutical companies, or other commercial
organizations that sponsor clinical trials, should adhere to the
Good Publication Practice guidelines for pharmaceutical
companies
http://www.gpp-guidelines.org/ , which are designed to
ensure that publications are produced in a responsible and
ethical manner. The guidelines also apply to any companies or
individuals that work on industry-sponsored publications, such
as freelance writers, contract research organizations and
communications companies.
The involvement of medical writers or anyone else who
assisted with the preparation of the manuscript content should
be acknowledged, along with their source of funding, as
described in the European Medical Writers Association (EMWA)
guidelines on the role of medical writers in developing
peer-reviewed publications
http://www.emwa.org/Mum/EMWAguidelines.pdf . If
medical writers are not listed among the authors, it is
important that their role be acknowledged explicitly. We suggest
wording such as 'We thank Jane Doe who provided
medical writing services on behalf of XYZ Pharmaceuticals
Ltd.'
Submission of a manuscript to CytoJournal implies that
readily reproducible materials described in the manuscript,
including all relevant raw data, will be freely available to any
scientist wishing to use them for non-commercial purposes.
Nucleic acid sequences, protein sequences, and atomic
coordinates should be deposited in an appropriate database in
time for the accession number to be included in the published
article. In computational studies where the sequence information
is unacceptable for inclusion in databases because of lack of
experimental validation, the sequences must be published as an
additional file with the article.
Any 'in press' articles cited within the references and
necessary for the reviewers' assessment of the manuscript should
be made available if requested by the editorial office.
Nucleotide sequences
Nucleotide sequences can be deposited with the
DNA Data Bank of Japan (DDBJ)
http://www.ddbj.nig.ac.jp/
,
European Molecular Biology Laboratory (EMBL/EBI) Nucleotide
Sequence Database
http://www.ebi.ac.uk/ , or
GenBank (National Center for Biotechnology Information)
http://www.ncbi.nlm.nih.gov/ .
Protein sequences
Protein sequences can be deposited with SwissProt
http://pubchem.ncbi.nlm.nih.gov/ or the Protein Information
Resource (PIR)
http://pir.georgetown.edu/ .
Structures
Protein structures can be deposited with one of the members of
the Worldwide Protein Data Bank
http://www.wwpdb.org/ . Nucleic Acids structures can
be deposited with the Nucleic Acid Database
http://ndbserver.rutgers.edu/ at Rutgers. Crystal
structures of organic compounds can be deposited with the
Cambridge Crystallographic Data Centre
http://www.ccdc.cam.ac.uk/products/csd/deposit/ .
Chemical structures and assays
Structures of chemical substances can be deposited with PubChem
Substance
http://pubchem.ncbi.nlm.nih.gov/ . Bioactivity screens of
chemical substances can be deposited with PubChem BioAssay
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pcassay .
Microarray data
Where appropriate, authors should adhere to the standards
proposed by the Microarray Gene Expression Data Society
http://www.mged.org/
and must deposit microarray data in one of the public
repositories, such as ArrayExpress
http://www.mged.org/ , Gene
Expression Omnibus (GEO)
http://www.ncbi.nlm.nih.gov/projects/geo/ or the Center for
Information Biology Gene Expression Database (CIBEX)
http://cibex.nig.ac.jp/ .
Computional modeling
We encourage authors to prepare models of biochemical reaction
networks using the Systems Biology Markup Language
http://sbml.org/index.php/Main_Page and to deposit the
model with the BioModels database
http://www.ebi.ac.uk/biomodels/ , as well as
submitting it as an additional file with the manuscript.
Plasmids
We encourage authors to deposit copies of their plasmids as DNA
or bacterial stocks with Addgene
http://www.addgene.org/pgvec1 , a non-profit
repository, or PlasmID
http://plasmid.med.harvard.edu/PLASMID/ , the Plasmid
Information Database at Harvard.
CytoJournal endorses the World Association of Medical Editors
(WAME) Policy Statement on Geopolitical Intrusion on Editorial
Decisions
http://www.wame.org/resources/policies
File formats
The following word processor file formats are acceptable for
the main manuscript document:
- Microsoft Word (version 2 and above)
- WordPerfect (version 5 and above)
- Rich text format (RTF)
- Portable document format (PDF)
Users of other word processing packages should save or
convert their files to RTF before uploading. Many free tools
are available which ease this process.
Note that
figures must be submitted as separate image files, not
as part of the submitted DOC/ PDF file.
Article types
CytoJournal considers the following types of
articles:
- Research article - reports of data from
original research.
- Methodology articles - present a new
experimental method, test or procedure. The method
described may either be completely new, or may offer a
better version of an existing method. The article must
describe a demonstrable advance on what is currently
available.
- Case reports - reports of clinical cases that
can be educational by discussing a diagnostic dilemma
and reporting relatively rare phenomenon or clinical
association.
- Quiz case- Presenting a clinical case to
communicate teaching point(s) by presenting it in a quiz
format to generate an inquisitive interest for
educational progress.
- Review - comprehensive, authoritative
descriptions of any subject within the scope of
CytoJournal; these articles are usually written by
opinion leaders that have been invited by the Editorial
Board.
- CytoJournal Monograph related review series -
comprehensive, authoritative descriptions of any subject
within the scope of CytoJournal; these reviews
are usually written by opinion leaders that have been
invited by the
CytoJournal Monograph committee
and peer-reviewed under leadership of
CytoJournal
Monograph Editorial Board.
- Editorials - short, focussed and opinionated
articles on any subject within the scope of
CytoJournal; these articles are usually related to a
contemporary issue, such as recent research findings,
and are often written by opinion leaders invited by the
Editorial Board.
- Book reviews - short summaries of the
strengths and weaknesses of a book; they should evaluate
its overall usefulness to the intended audience.
- Letters to the editor - short, focussed and
opinionated brief letter on any subject within the scope
of CytoJournal; these articles are usually
related to a contemporary issue, written by readers.
Please read the descriptions of each of the article
types, choose which is appropriate for your article and
structure it accordingly.
Some type of articles (research articles, methodology
articles, case reports, quiz cases, review articles, and
Cytojournal monograph articles) require at least 3 multiple
choice questions for CME. For general guidelines, please
use the following manual available free online:
Constructing Written Test Questions For the Basic and
Clinical Sciences
http://www.nbme.org/PDF/ItemWriting_2003/2003IWGwhole.pdf
If in doubt, your manuscript should be classified as
Research, the structure for which is described below.
Manuscript sections for Research articles
Manuscripts for Research articles submitted to
CytoJournal should be divided into the following
sections:
You can
download a template (First page
general,
Manuscript case report,
Manuscript general) for your article. For instructions
on use, see
below.
The Accession Numbers of any nucleic acid
sequences, protein sequences or atomic coordinates cited in
the manuscript should be provided, in square brackets and
include the corresponding database name; for example,
[EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812,
GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].
The databases for which we can provide direct links are:
EMBL Nucleotide Sequence Database (EMBL),
DNA Data Bank of Japan (DDBJ
), GenBank at the NCBI (GenBank),
Protein Data Bank (PDB),
Protein Information Resource (PIR)
and the Swiss-Prot Protein Database (Swiss-Prot).
Title page
This should list the title of the article. The title
should include the study design, for example:
A versus B in the treatment of C: a randomized
controlled trial
X is a risk factor for Y: a case control study
The full names, institutional addresses, and e-mail
addresses for all authors must be included on the title
page. The corresponding author should also be indicated.
Abstract
The abstract of the manuscript should not exceed 350 words
and must be structured into separate sections: Background,
the context and purpose of the study; Methods, how
the study was performed and statistical tests used;
Results, the main findings; Conclusions, brief
summary and potential implications.
Please minimize the use of abbreviations and do
not cite references in the abstract.
Trial registration, if your research article
reports the results of a controlled health care
intervention, please list your trial registry, along with
the unique identifying number, e.g. Trial registration:
Current Controlled Trials ISRCTN73824458. Please note that
there should be no space between the letters and numbers of
your trial registration number.
Background
The background section should be written from the standpoint
of researchers without specialist knowledge in that area and
must clearly state - and, if helpful, illustrate - the
background to the research and its aims. Reports of clinical
research should, where appropriate, include a summary of a
search of the literature to indicate why this study was
necessary and what it aimed to contribute to the field. The
section should end with a very brief statement of what is
being reported in the article.
Methods
This should include the design of the study, the setting,
the type of participants or materials involved, a clear
description of all interventions and comparisons, and the
type of analysis used, including a power calculation if
appropriate.
Results and Discussion
The Results and Discussion may be combined into a single
section or presented separately. Results of statistical
analysis should include, where appropriate, relative and
absolute risks or risk reductions, and confidence intervals.
The results and discussion sections may also be broken into
subsections with short, informative headings.
Conclusions
This should state clearly the main conclusions of the
research and give a clear explanation of their importance
and relevance. Summary illustrations may be included.
List of abbreviations used in the article (in
alphabetic order)
If abbreviations are used in the text either they should be
defined in the text where first used, or a list of
abbreviations can be provided, which should precede
the competing interests and authors' contributions.
Competing interests
A competing interest exists when your interpretation of data
or presentation of information may be influenced by your
personal or financial relationship with other people or
organizations. Authors should disclose any financial
competing interests but also any non-financial competing
interests that may cause them embarrassment were they to
become public after the publication of the manuscript.
Authors are required to complete a declaration of
competing interests. All competing interests that are
declared will be listed at the end of published articles.
Where an author gives no competing interests, the listing
will read 'The author(s) declare that they have no competing
interests'.
When completing your declaration, please consider the
following questions:
Financial competing interests
- In the past five years have you received
reimbursements, fees, funding, or salary from an
organization that may in any way gain or lose
financially from the publication of this manuscript,
either now or in the future? Is such an organization
financing this manuscript (including the
article-processing charge)? If so, please specify.
- Do you hold any stocks or shares in an organization
that may in any way gain or lose financially from the
publication of this manuscript, either now or in the
future? If so, please specify.
- Do you hold or are you currently applying for any
patents relating to the content of the manuscript? Have
you received reimbursements, fees, funding, or salary
from an organization that holds or has applied for
patents relating to the content of the manuscript? If
so, please specify.
- Do you have any other financial competing interests?
If so, please specify.
Non-financial competing interests
Are there any non-financial competing interests
(political, personal, religious, ideological, academic,
intellectual, commercial or any other) to declare in
relation to this manuscript? If so, please specify.
If you are unsure as to whether you, or one your
co-authors, has a competing interest please discuss it with
the editorial office.
Authors' contributions
In order to give appropriate credit to each author of a
paper, the individual contributions of authors to the
manuscript should be specified in this section.
An "author" is generally considered to be someone who has
made substantive intellectual contributions to a published
study. To qualify as an author one should 1) have made
substantial contributions to conception and design, or
acquisition of data, or analysis and interpretation of data;
2) have been involved in drafting the manuscript or revising
it critically for important intellectual content; and 3)
have given final approval of the version to be published.
Each author should have participated sufficiently in the
work to take public responsibility for appropriate portions
of the content. Acquisition of funding, collection of data,
or general supervision of the research group, alone, does
not justify authorship.
We suggest the following kind of format (please use
initials to refer to each author's contribution): AB carried
out the molecular genetic studies, participated in the
sequence alignment and drafted the manuscript. JY carried
out the immunoassays. MT participated in the sequence
alignment. ES participated in the design of the study and
performed the statistical analysis. FG conceived of the
study, and participated in its design and coordination and
helped to draft the manuscript. All authors read and
approved the final manuscript.
All contributors who do not meet the criteria for
authorship should be listed in an acknowledgements section.
Examples of those who might be acknowledged include a person
who provided purely technical help, writing assistance, or a
department chair who provided only general support.
Acknowledgements
Please acknowledge anyone who contributed towards the study
by making substantial contributions to conception, design,
acquisition of data, or analysis and interpretation of data,
or who was involved in drafting the manuscript or revising
it critically for important intellectual content, but who
does not meet the criteria for authorship. Please also
include their source(s) of funding. Please also acknowledge
anyone who contributed materials essential for the study.
The role of a medical writer must be included in the
acknowledgements section, including their source(s) of
funding.
Authors should obtain permission to acknowledge from all
those mentioned in the Acknowledgements.
Please list the source(s) of funding for the study, for
each author, and for the manuscript preparation in the
acknowledgements section. Authors must describe the role of
the funding body, if any, in study design; in the
collection, analysis, and interpretation of data; in the
writing of the manuscript; and in the decision to submit the
manuscript for publication.
References
All references must be numbered consecutively, in square
brackets, in the order in which they are cited in the text,
followed by any in tables or legends. Reference citations
should not appear in titles or headings. Each reference must
have an individual reference number. Please avoid excessive
referencing. If automatic numbering systems are used, the
reference numbers must be finalized and the bibliography
must be fully formatted before submission.
Only articles and abstracts that have been published or
are in press, or are available through public
e-print/preprint servers, may be cited; unpublished
abstracts, unpublished data and personal communications
should not be included in the reference list, but may be
included in the text. Notes/footnotes are not allowed.
Obtaining permission to quote personal communications and
unpublished data from the cited author(s) is the
responsibility of the author. Journal abbreviations follow
Index Medicus/MEDLINE. Citations in the reference list
should contain all named authors, regardless of how many
there are.
We encourage authors to use a recent version of EndNote
(version 5 and above) or Reference Manager (version 10) when
formatting their reference list, as this allows references
to be automatically extracted. Authors submitting articles
in EndNote 5 or higher or Reference Manager 10 format will
save ‘30 on the ‘750 (‘985, US$1505) article processing
charge. In order to obtain this discount, you should upload
the manuscript file containing your EndNote or Reference
Manager-formatted bibliography as a .doc file. Please ensure
you do not convert to another format (e.g. RTF or PDF). On
upload, the discount will be automatically granted and you
will receive a confirmation on-screen and by email. You will
also be able to preview an HTML version of the extracted
references during submission, and we urge authors to check
this. EndNote or Reference Manager users should also make
sure that any changes made to the reference list are done
within their reference management program, rather than by
manually editing the formatted bibliography. This is because
manually introduced changes will not be picked up in the
automatically extracted list.
Examples of the CytoJournal reference style are
shown below. Please take care to follow the reference style
precisely; references not in the correct style may be
retyped, necessitating tedious proofreading.
Download a PowerPoint presentation on common reference styles and using the reference checking facility on the manuscript submission site.
Links
Web links and URLs should be included in the reference list.
They should be provided in full, including both the title of
the site and the URL, in the following format: The Mouse
Tumor Biology Database
[http://tumor.informatics.jax.org/cancer_links.html]
CytoJournal reference style
Article within a journal
1. Shidham VB, Kumar N, Narayan R, Brotzman GL. Should LSIL
with ASC-H (LSIL-H) in cervical smears be an independent
category? A study on SurePathTM specimens with
review of literature.
CytoJournal 2007,4:7
Free full text is available at:
http://www.cytojournal.com/content/4/1/7
PDF at:
http://www.cytojournal.com/content/pdf/1742-6413-4-7.pdf
Article within a journal supplement
2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I:
Analysis and assessment of ab initio three-dimensional
prediction, secondary structure, and contacts prediction. Proteins
1999, 43(Suppl 3):149-170.
In press article
3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled
nitric oxide. Eur Respir J, in press.
Published abstract
4. D'Amore K, Varsegi G, Goswami M, Dawson G, Shidham
V. Critical evaluation of D2-40 (podoplanin) from two
vendors in relation to the differential diagnosis of
mesothelial lesions [abstract].Modern Pathology
2008,21:s1A-396A (Abstract no.1657)
Article within conference proceedings
5. Jones X: Zeolites and synthetic mechanisms. In
Proceedings of the First National Conference on Porous
Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y.
Stoneham: Butterworth-Heinemann; 1996:16-27.
Book chapter, or article within a book
6. Shidham VB. Respiratory Cytology. In Atkinson Atlas of
Diagnostic Cytopathology., Second edition. Edited by
Atkinson BF. Philadelphia, PA: W. B. Saunders Company; 2004,
273-356.
Whole issue of journal
7. Ponder B, Johnston S, Chodosh L (Eds): Innovative
oncology. In Breast Cancer Res 1998, 10:1-72.
Whole conference proceedings
8. Smith Y (Ed): Proceedings of the First National
Conference on Porous Sieves: 27-30 June 1996; Baltimore.
Stoneham: Butterworth-Heinemann; 1996.
Complete book
9. Shidham VB and Atkinson BF. ‘Cytopathologic Diagnosis
of Serous Fluids‘ Multi-author book with 15 chapters,
Elsevier (W. B. Saunders Company) First edition, 2007.
Monograph or book in a series
10. Hunninghake GW, Gadek JE: The alveolar macrophage. In
Cultured Human Cells and Tissues. Edited by Harris TJR.
New York: Academic Press; 1995:54-56. [Stoner G (Series
Editor): Methods and Perspectives in Cell Biology,
vol 1.]
Book with institutional author
11. Papanicolaou Society of Cytopathology Guidelines for
Compliance with Medicare Rules Regarding Ordering of
Ancillary Pathologic Tests. Member- ‘Practice Guidelines
Task Force‘, The Papanicolaou Society of Cytopathology.
12. Shidham V, Cramer H. Elsheikh TM, Layfield LJ.
Papanicolaou Society of Cytopathology Guidelines for
Specimen Adequacy and Quality Indicators in Cytopathology
Reports. Member- ‘Practice Guidelines Task Force‘,
The Papanicolaou Society of Cytopathology.
Link / URL
13. The Mouse Tumor Biology Database
[http://tumor.informatics.jax.org/cancer_links.html]
Microsoft Word template
Although we can accept manuscripts prepared as Microsoft
Word, Word Perfect, RTF or PDF files, we have designed a
Microsoft Word template that can be used to generate a
standard style and format for your article. It can be used
if you have not yet started to write your paper, or if it is
already written and needs to be put into CytoJournal
style.
Download the template from our site (First page
general,
Manuscript case report,
Manuscript general), and save it to your
hard drive. Double click the template to open it.
How to use the CytoJournal template
The template consists of a standard set of headings that
make up a CytoJournal Research manuscript, along with
dummy fragments of body text. Follow these steps to create
your manuscript in the standard format:
- Replace the dummy text for Title, Author details,
Institutional affiliations, and the other sections of
the manuscript with your own text (either by entering
the text directly or by cutting and pasting from your
own manuscript document).
- If there are sections which you do not need,
delete them (but check the rest of the Instructions for
Authors to see which sections are compulsory).
- If you need an additional copy of a heading (e.g.
for additional figure legends) just copy and paste.
- For the references, you may either manually enter
the references using the
reference style given, or use bibliographic software
to insert them automatically.
Preparing illustrations and
figures
Figures should be provided as separate files and should
not be included in the main text of the submitted
manuscript. Each figure should comprise only a single file.
There is no charge for the use of color.
Formats
The following file formats of max. 1MB size can be accepted
online: (How
to reduce the image file size)
- PNG (preferred format for photos or images)
- PowerPoint (Each figure must be a single slide
in each Powerpoint file)
- JPEG
Figure legends
The legends should be included in the main manuscript text
file immediately following the references, rather than being
a part of the figure file. For each figure, the following
information should be provided: Figure number (in sequence,
using Arabic numerals - i.e. Figure 1, 2, 3 etc); short
title of figure with detailed legend, up to 300 words.
Please note that it is the responsibility of the
author(s) to obtain permission from the copyright holder
to reproduce figures or tables that have previously been
published elsewhere.
Preparing tables
Each table should be numbered in sequence using Arabic
numerals (i.e. Table 1, 2, 3 etc.). Tables should also have
a title that summarizes the whole table, maximum 15 words.
Detailed legends may then follow, but should be concise.
Smaller tables considered to be integral to the
manuscript can be pasted into the end of the document text
file, in portrait format (note that tables on a landscape
page must be reformatted onto a portrait page or submitted
as additional files). These will be typeset and displayed in
the final published form of the article. Such tables should
be formatted using the 'Table object' in a word processing
program to ensure that columns of data are kept aligned when
the file is sent electronically for review; this will not
always be the case if columns are generated by simply using
tabs to separate text. Columns and rows of data should be
made visibly distinct by ensuring the borders of each cell
display as black lines. Commas should not be used to
indicate numerical values. Color and shading should not be
used.
Style and language
General
Currently, CytoJournal can only accept manuscripts written in
English.Spelling should be US English only. Please DONOT use British English or a mixture with other spellings. For information http://en.wikipedia.org/wiki/American_English.
Gene names should be in italic, but protein products should be in
plain type.
There is no explicit limit on the length of articles submitted,
but authors are encouraged to be concise. There is no restriction on
the number of figures, tables or additional files that can be
included with each article online. Figures and tables should be
sequentially referenced. Authors should include all relevant
supporting data with each article.
CytoJournal will not edit submitted manuscripts for style
or language; reviewers may advise rejection of a manuscript if it is
compromised by grammatical errors. Authors are advised to write
clearly and simply, and to have their article checked by colleagues
before submission. In-house copyediting will be minimal. Non-native
speakers of English may choose to make use of a copyediting service.
Help and advice on scientific writing
Click
here to read
Abbreviations
Abbreviations should be used as sparingly as possible. They can be
defined when first used or a list of abbreviations can be provided
preceding the acknowledgements and references.
Typography
- Please use double line spacing.
- Type the text unjustified, without hyphenating words at line
breaks.
- Use hard returns only to end headings and paragraphs, not to
rearrange lines.
- Capitalize only the first word, and proper nouns, in the
title.
- All pages should be numbered.
- Use the CytoJournal reference format.
- Footnotes to text should not be used.
- Greek and other special characters may be included. If you
are unable to reproduce a particular special character, please
type out the name of the symbol in full.
Please ensure that all special characters used are embedded
in the text, otherwise they will be lost during conversion to
PDF.
Units
SI Units should be used throughout (liter and molar are permitted,
however).
Technical support for online
submission difficulty: systems @ medknow . comEditorial support with
academic questions and other queries:
cytojournal @ mcw . edu
